RSS Feed Print
Merck, GE Team Up for New Alzheimer's Treatment
Myriam
Posted: Wednesday, December 19, 2012 3:12 PM
Joined: 12/6/2011
Posts: 3326


(Source: msn.com) - Is Merck's pursuit of late-stage Alzheimer's patients the case of a fool rushing in where angels have chosen not to tread? The N.J. pharmaceutical giant obviously doesn't think so. Furthermore, Merck believes it may have an ace in the hole as it pursues development of what it hopes will be an Alzheimer's blockbuster.


Merck is counting on an imaging agent from General Electric Health Care to work in tandem with its investigational drug MK-8931 to determine if the medicine is successfully obstructing an enzyme that can cut back the development of beta amyloid. 

The GE imaging agent, called flutemetamol, is injected into patients before positron emission tomography (PET) scans to detect beta amyloid deposits in the brain. Although the agent is still in development, it showed promising results in a late-stage study.


Go to full story:
http://money.msn.com


Mimi S.
Posted: Wednesday, December 19, 2012 3:47 PM
Joined: 11/29/2011
Posts: 7029


More evidence that we must diagnose while victims are still in early stage!!!!!!